U.S. Supreme Court Denies Celanese Petition in Acesulfame Potassium Patent Dispute
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Celanese Corp. v. International Trade Commission |
| Case Number | 24-635 |
| Court | U.S. Supreme Court, District of Columbia |
| Duration | Dec 2024 – Apr 2025 140 days |
| Outcome | Petition Denied / Dismissed |
| Patents at Issue |
Case Overview
The Parties
⚖️ Petitioner
Global specialty materials and chemical company with a diversified portfolio spanning engineered materials, acetyl products, and food-grade ingredients. Holder of key Ace-K IP.
🛡️ Respondent
Federal quasi-judicial agency empowered to investigate and remedy unfair import practices, including patent infringement. Its rulings were challenged by Celanese.
Patents at Issue
This dispute centered on three U.S. patents covering compositions and processes for producing acesulfame potassium (Ace-K), a widely used artificial sweetener:
- • US10590095B2 — Acesulfame potassium compositions and production processes
- • US10023546B2 — Acesulfame potassium compositions and production processes
- • US10208004B2 — Acesulfame potassium compositions and production processes
Developing a similar chemical process or composition?
Check if your technology might infringe these or related patents.
The Verdict & Legal Analysis
Outcome
The Supreme Court denied Celanese’s petition, formally closing the case with a “petition dismissed” designation. This leaves intact prior rulings, likely from the ITC and Federal Circuit, regarding the patentability and validity of Celanese’s Ace-K patents. No damages or injunctive relief were independently issued at this stage.
Key Legal Issues
The core dispute centered on whether Celanese’s three Ace-K patents satisfied statutory requirements for patentability, likely involving challenges under 35 U.S.C. § 102 (novelty), § 103 (obviousness), or § 112 (enablement/written description). The denial of certiorari indicates the Court found no compelling reason to disturb the existing record.
Drafting complex chemical claims?
Learn from this case. Use AI to draft stronger claims that can withstand validity challenges.
Power Your Patent Strategy with PatSnap Eureka IP
From novelty searches to patent drafting, PatSnap Eureka’s AI-powered tools help you navigate the patent landscape with confidence.
⚠️ Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in specialty chemical processes and compositions. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation on chemical patentability.
- View all related patents in this technology space
- See which companies are most active in chemical process patents
- Understand claim construction patterns for Ace-K
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own chemical technology or product.
- Input your process description or chemical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Acesulfame potassium production processes
3 Patents at Issue
In Ace-K composition & process space
Process Patents
May offer narrower, durable protection
✅ Key Takeaways
For Patent Attorneys & Litigators
Supreme Court certiorari denial in ITC patent cases is common, setting a high bar for review.
Search related case law →Invalidity/cancellation defenses at the ITC can effectively neutralize complex process and composition patent portfolios.
Explore precedents →For R&D Teams & IP Professionals
Conduct updated FTO analysis on Acesulfame Potassium manufacturing processes and compositions, especially for new formulations.
Start FTO analysis for my product →Process patents can provide durable protection even when broader composition claims face validity risks.
Try AI patent drafting →Ready to Strengthen Your Patent Strategy?
Join thousands of IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.